This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Innovations in Cancer Treatment by Chong-Oh Kim
Introduction
Chong-Oh Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical technology, particularly in cancer treatment. His innovative approach focuses on the use of radioactive magnetic fluids, which have the potential to revolutionize cancer diagnosis and therapy.
Latest Patents
Chong-Oh Kim holds a patent for "Radioactive magnetic fluids for treatment or diagnosis of cancer, process for preparing them and use thereof." This invention relates to the development of radioactive magnetic fluids that include components capable of emitting β-ray and γ-ray radiation. The β radiation is effective in killing tumor cells, while the γ radiation can be easily imaged using a γ-camera. This allows for targeted treatment, minimizing side effects associated with traditional cancer therapies. The invention also features a unique formulation that enhances the stability and dispersion of magnetic nanoparticles in water, making it suitable for therapeutic and diagnostic applications.
Career Highlights
Throughout his career, Chong-Oh Kim has focused on innovative solutions in the medical field. His work on radioactive magnetic fluids demonstrates his commitment to advancing cancer treatment methodologies. With a patent portfolio that includes this groundbreaking invention, he has established himself as a key figure in medical research and development.
Collaborations
Chong-Oh Kim has collaborated with notable colleagues, including Yuqiang Huang and Jong-Hee Kim. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Chong-Oh Kim's innovative work in the field of cancer treatment through radioactive magnetic fluids showcases his dedication to improving patient outcomes. His contributions are paving the way for new therapeutic options in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile